review Open AccessTop 1% cited

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Leukemia · 2018 · Vol. 32(5) · pp. 1057–1069

Tiziano Barbui(Ospedale Papa Giovanni XXIII)Ayalew Tefferi(Mayo Clinic in Arizona)Alessandro M. Vannucchi(University of Florence)Francesco Passamonti(University of Insubria)Richard T. Silver(Cornell University)Ronald Hoffman(Icahn School of Medicine at Mount Sinai)Srđan Verstovšek(The University of Texas MD Anderson Cancer Center)Ruben A. Mesa(The University of Texas Health Science Center at San Antonio)Jean‐Jacques Kiladjian(Inserm)Rȕdiger Hehlmann(Heidelberg University)Andreas Reiter(Heidelberg University)Francisco Cervantes(Hospital Clínic de Barcelona)Claire Harrison(Guy's and St Thomas' NHS Foundation Trust)Mary Frances Mc Mullin(Queen's University Belfast)Hans Carl Hasselbalch(Zealand University Hospital)Steffen Koschmieder(RWTH Aachen University)Monia Marchetti(Azienda Sanitaria Locale di Asti)Andrea Bacigalupo(Università Cattolica del Sacro Cuore)Guido Finazzi(Ospedale Papa Giovanni XXIII)Nicolaus Kroeger(Universität Hamburg)Martin Grießhammer(Johannes Wesling Klinikum Minden)Gunnar Birgegård(Uppsala University)Giovanni Barosi✉(Foundation Center)

View via DOI Full-text PDF

Myeloproliferative Neoplasms: Diagnosis and Treatment Acute Myeloid Leukemia Research Kruppel-like factors researchMedicineRuxolitinibMyelofibrosisInternal medicinePolycythemia veraTransplantationRandomized controlled trialOncologySurgeryBone marrow

MeSH terms

EuropeHumansMyeloproliferative DisordersNeoplasmsNitrilesPhiladelphia ChromosomePyrazolesPyrimidinesSplenomegalyRandomized Controlled Trials as TopicDisease ManagementStem Cell Transplantation